Bionano Genomics Inc

Change company Symbol lookup

Select an option...

BNGO Bionano Genomics Inc

CNXA Connexa Sports Technologies Inc

MORF Morphic Holding Inc

STOK Stoke Therapeutics Inc

DUOT Duos Technologies Group Inc

BCLI Brainstorm Cell Therapeutics Inc

EEX Emerald Holding Inc

JPM-L JPMorgan Chase & Co

SBFM Sunshine Biopharma Inc

SEKEY Seiko Epson Corp

Go

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.